Aims and Scope
Cancer Letters is a peer-reviewed medical journal established in 1975 that focuses on the rapid publication of original research on multidisciplinary aspects of cancer. The editor-in-chief is M. Schwab.
Key Metrics
16.1
CiteScore
CiteScore
CiteScore measures average citations received per document published in the serial.
0.01 - 0.05
Eigenfactor
Eigenfactor
Eigenfactor Score measures the number of times articles from the journal published in the past five years have been cited. This does not include self citations.
5 - 10
Impact Factor
Impact Factor
Impact factor of a journal is calculated by dividing the number of current year citations to the source items published in that journal during the previous two years.
203
H index
H-Index
Journal's h-index reflects the collective citation impact of the authors publishing in the journal. The h-index is defined as the maximum value of h such that the given journal has published at least h papers that have each been cited at least h times.
0.93
5-Year SI
5-year SI
- N/A 2-year SI
- 0.9 Lifetime SI
Scite Index
Scite Index
scite Index is the ratio of citations supporting research which is published in the journal to sum of citations either supporting or contrasting the research published in the journal for the same time period. Minimum 100 supporting citations required.
Q1
Oncology
SJR
- Q1 Oncology
- Q1 Cancer Research
SJR
SJR
SCImago Journal Rank measures weighted citations received by the serial. Citation weighting depends on subject field and prestige (SJR) of the citing serial.
1.69
SNIP
SNIP
Source Normalized Impact per Paper measures actual citations received relative to citations expected for the serial’s subject field.
3 Mo
Time to Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Topics Covered
- Cancer
- Carcinogenesis
- Immune system
- Extracellular vesicles
- Hepatocellular carcinoma
- Lung cancer
- Radiation
- Immunotherapy
- Head and neck
- Oxidative stress
- Breast cancer
- Autophagy
- Epidermal growth factor receptor
- Glycolysis
- Gemcitabine
- DNA damage
- Tumor growth
- Breast cancer cells
- Fibronectin
- Tumor progression
Journal Specifications
| Overview | |
| Publisher | ELSEVIER IRELAND LTD |
| Language | English |
| Frequency | Fortnightly |
| General Details | |
| Language | English |
| Frequency | Fortnightly |
| Publication Start Year | 1975 |
| Publisher URL | Visit website |
| Website URL | Visit website |
Planning to publish in Cancer Letters ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Looking for the right journals to submit your mansucript?
Upload your manuscript and get a submission readiness score and other journal recommendations.
Check my PaperRecently Published Papers
-
Full paper
CDK5RAP3 is a novel super-enhancer-driven gene activated by master TFs and regulates ER-Phagy in neuroblastoma
- 1 Apr 24
- Cancer Letters
-
Full paper
Editorial Board
- 1 Apr 24
- Cancer Letters
-
Full paper
Editorial Board
- 1 Mar 22
- Cancer Letters
-
Full paper
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity
- 1 Mar 22
- Cancer Letters
-
Full paper
Editorial Board
- 1 Mar 22
- Cancer Letters
-
Full paper
Tumor-derived miR-378a-3p-containing extracellular vesicles promote osteolysis by activating the Dyrk1a/Nfatc1/Angptl2 axis for bone metastasis
- 1 Feb 22
- Cancer Letters
Scite analysis
Powered by scite_
17.7k articles received 450.3k citations see all
- 17,579 Supporting
- 424,739 Mentioning
- 1,907 Contrasting
Editorial notices
- 33 Retractions
- 10 Withdrawals
- 0 Corrections
- 172 Errata
- 1 Expression of Concern
Time To Publish
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
Time to Publish
Based on turnaround time from submission to publication for papers (articles & reviews) published in 2022 and for journals with a sample of more than 10 papers.
% of papers by time taken from submission to publication
0 to 3 months
55%
4 to 6 months
35%
7 to 9 months
8%
Above 9 months
1%
Did you find this useful?
Thank you for your feedback.
FAQs
How long has Cancer Letters been actively publishing?
Cancer Letters has been in operation since 1975 till date.
What is the publishing frequency of Cancer Letters ?
Cancer Letters published with a Fortnightly frequency.
How many articles did Cancer Letters publish last years ?
In 2023, Cancer Letters published 0 articles.
What is the eISSN & pISSN for Cancer Letters ?
For Cancer Letters,eISSN is 1872-7980 and pISSN is0304-3835.
What is Citescore for Cancer Letters ?
Citescore for Cancer Letters is 16.1.
What is H index for Cancer Letters ?
H index for Cancer Letters is 203.
What is SNIP score for Cancer Letters ?
SNIP score for Cancer Letters is 1.69.
What is the SJR for Cancer Letters ?
SJR for Cancer Letters is Q1.
Who is the publisher of Cancer Letters ?
ELSEVIER IRELAND LTD is the publisher of Cancer Letters.